<DOC>
	<DOCNO>NCT02936921</DOCNO>
	<brief_summary>Several decade ago , France make choice implement national prevention program congenital toxoplasmosis . The identification first trim pregnancy pregnant woman susceptible Toxoplasma infection mandatory since 1985 . In 1992 , decision make extent program monthly retesting woman identify immune , attempt reduce number severely infected child . The systematic detection maternal congenital infection generate many question clinician , biologist , parent old patient , short long-term prognosis congenital toxoplasmosis , best test use diagnose infection mother child , efficacy exist treatment , manage patient long-term . The need answer many question prompt medical team work within laboratory outpatient department Parasitology Department Croix-Rousse Hospital Lyon implement clinical research program . It base systematic inclusion cohort pregnant woman whose infection confirm , follow , order monitor outcome pregnancy 2 ) follow child order confirm infection rule . All congenitally infect subject undergo clinical examination , serological test ocular examination least year without age limit . The following data prospectively collect dedicated database : gestational age maternal infection correspond serological profile ; type date maternal treatment ; finding ultrasound test amniotic fluid analysis ; serological clinical finding birth ; type date postnatal treatment ; postnatal serological profile ; infection status one year age ; long term clinical ( ophthalmologic ) et serological finding . These data allow produce original finding risk maternal-foetal transmission accord gestational age maternal infection , long term ophthalmological outcome congenital toxoplasmosis offer guideline diagnosis , treatment follow-up maternal congenital infection . These effort still maintain future order - analyse impact puberty , pregnancy , adult co-morbidities risk ophthalmological event - increase precision around risk estimate materno-foetal transmission , - continue innovate term diagnostic strategy improve test performance reduce cost - explore new potential clinical outcome neuropsychiatric disorder associate congenital postnatal infection - determine infection due oocysts could different clinical outcome due ingestion cyst - ass efficacy treatment maternal congenital infection</brief_summary>
	<brief_title>Lyon Cohort Maternal Congenital Toxoplasma Infections</brief_title>
	<detailed_description />
	<mesh_term>Toxoplasmosis</mesh_term>
	<mesh_term>Toxoplasmosis , Congenital</mesh_term>
	<criteria>Confirmation laboratory maternal infection estimate occur pregnancy 12 week precede conception . maternal : infection could confirm reference laboratory</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Toxoplasma gondii</keyword>
	<keyword>Toxoplasmosis</keyword>
	<keyword>congenital</keyword>
	<keyword>prenatal</keyword>
	<keyword>screen</keyword>
	<keyword>treatment</keyword>
	<keyword>diagnosis</keyword>
</DOC>